D. Ka-Ho Wong

One-Year Entecavir or Lamivudine Therapy Results in Reduction of Hepatitis B Virus Intrahepatic Covalently Closed Circular DNA Levels

M. Yuen, J. Fung, Ching-lung Lai, 2005, Antiviral therapy.

Impact of precore and core promoter mutations on hepatic histology in patients with chronic hepatitis B

M. Yuen, Irene Oi-Lin Ng, Clinton Lai, 2005, Alimentary pharmacology & therapeutics.

Randomized trial of lamivudine versus entecavir in entecavir‐treated patients with undetectable hepatitis B virus DNA: Outcome at 2 Years

I. Hung, M. Yuen, J. Fung, 2011, Hepatology.

Occult hepatitis B infection and hepatocellular carcinoma: epidemiology, virology, hepatocarcinogenesis and clinical significance.

M. Yuen, D. Wong, G. Raimondo, 2020, Journal of hepatology.

The relationship between HBV‐DNA levels and cirrhosis‐related complications in Chinese with chronic hepatitis B

M. Yuen, D. Wong, E. Sablon, 2005, Journal of viral hepatitis.

Precore and core promoter mutations at the time of HBeAg seroclearance in Chinese patients with chronic hepatitis B.

M. Yuen, J. Doutreloigne, E. Sablon, 2007, The Journal of infection.

Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis.

M. Yuen, J. Fung, W. Seto, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.